Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Total Current Liabilities (2016 - 2025)

Firefly Neuroscience has reported Total Current Liabilities over the past 15 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $2.8 million for Q4 2025, down 43.35% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (down 43.35% YoY), and the annual figure for FY2025 was $2.8 million, down 43.35%.
  • Total Current Liabilities for Q4 2025 was $2.8 million at Firefly Neuroscience, up from $2.7 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for AIFF hit a ceiling of $7.2 million in Q1 2025 and a floor of $1.9 million in Q2 2024.
  • Median Total Current Liabilities over the past 5 years was $2.8 million (2025), compared with a mean of $3.1 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 261.08% in 2021 and later plummeted 55.79% in 2024.
  • Firefly Neuroscience's Total Current Liabilities stood at $2.0 million in 2021, then soared by 96.2% to $3.9 million in 2022, then tumbled by 34.88% to $2.5 million in 2023, then surged by 96.52% to $5.0 million in 2024, then plummeted by 43.35% to $2.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $2.8 million (Q4 2025), $2.7 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.